TL;DR: A 2026 study in JAMA Network Open found that a therapy built to restore reward and positive emotion outperformed a matched negative-affect therapy for adults with depression, anxiety, and severely low positive affect. Key Findings PAT beat the matched therapy: Positive Affect Treatment improved the composite clinical-status outcome more than Negative Affect Treatment (d …
TL;DR: A 2026 rat study in Psychopharmacology found that THC exposure during late adolescence left adult animals with elevated anxiety-like behavior and impaired object-recognition and spatial-memory performance after a drug-free recovery period. Key Findings Adolescent THC exposure produced lasting anxiety-like behavior in adulthood: Rats given THC (5 mg/kg/day) from postnatal day 42 to 62 (late …
Cannabinoids Had Weak Evidence for Mental Disorders TL;DR: A Lancet Psychiatry review of randomized trials found little support for routine cannabinoid treatment in common mental disorders, despite possible weak signals in a few narrower conditions. Key Findings 54 randomized controlled trials were reviewed: The analysis covered 2,477 participants across mental disorders and substance-use disorders. Routine …
How Astrocytes Help the Amygdala Store Fear Memories TL;DR: Amygdala astrocytes were not passive support cells: their calcium signals tracked learned fear states and were required for neuronal fear-memory representations in mice. Key Findings In vivo BLA imaging across multiple mouse cohorts: The team combined astrocyte and neuronal calcium imaging, electrophysiology, and circuit manipulations in …
150 mg Caffeine Did Not Trigger Panic Disorder Anxiety TL;DR: A normal coffee-sized caffeine dose did not trigger a subjective anxiety surge in panic disorder, but it did make people more physiologically aroused, more avoidant, and more distracted by bodily sensations. Key Findings 150 mg did not raise subjective anxiety: The primary outcome did not …
Hormone Therapy Linked to 44% Improvement in Menopause Mood Symptoms TL;DR: Menopausal hormone therapy tracked with a 44.59% improvement in mood-symptom scores after about 107 days, across both peri- and postmenopausal women — and the gains were broadly similar regardless of which hormonal regimen was used. Key Findings 44.59% improvement in mood symptoms: After initiating …
Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes TL;DR: In Swedish registry data covering nearly 100,000 people with depression or anxiety, psychiatric hospital visits and sickness absence were 42% lower during semaglutide treatment periods — with comparable reductions in depression, anxiety, and substance-use outcomes. Key Findings 42% lower psychiatric care during semaglutide periods: Psychiatric hospital …
Exercise Beats Medication for Depression, But Which Type Matters Most? TL;DR: Aerobic exercise matches antidepressant efficacy for depression with effect size −1.60, resistance training slightly edges aerobic for anxiety, and neither requires meeting WHO guidelines—20 minutes three times weekly still produces clinical improvement. Depression responds to a treatment that’s free, legal, and accessible: exercise. But …
Fluorinated Psilocin: The Sub-Hallucinogenic Breakthrough TL;DR: Chemists designed a new psilocin derivative with fluorine modifications that induces sub-hallucinogenic effects in mice, sidestepping the acute psychological effects of classic psychedelics while retaining therapeutic serotonin receptor activity. Psilocybin has emerged as a clinical darling—mounting evidence shows rapid relief for depression, anxiety, and cluster headaches. But there’s a …
The Brain That Won’t Shut Down: How Fragmented REM Sleep Breeds Depression TL;DR: Chronic insomnia fragments REM sleep through persistent hyperarousal, preventing emotional memory consolidation and creating a vicious cycle that breeds depression—but cognitive-behavioral therapy for insomnia can break the cycle faster than antidepressants alone. Insomnia has a hidden mechanism. You lie awake for hours, …
